Document is current

Any future updates will be listed below

Pharmacokinetics of Sublingual Buprenorphine and Naloxone in Subjects with Mild to Severe Hepatic Impairment (Child-Pugh Classes A, B, and C), in Hepatitis C Virus-Seropositive Subjects, and in Healthy Volunteers

Crossref DOI link: https://doi.org/10.1007/s40262-015-0238-6

Published Online: 2015-01-21

Published Print: 2015-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark